CAPECITABINE, CAPECITABINE, PEMBROLIZUMAB
UC-BCG-2211, CAPPA
Phase 2 small_molecule active
Quick answer
CAPECITABINE, CAPECITABINE, PEMBROLIZUMAB for Triple Negative Breast Cancer with residual disease after neoadjuvant chemo-immunotherapy. is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Triple Negative Breast Cancer with residual disease after neoadjuvant chemo-immunotherapy.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active